Glycoprotein YKL-40

A potential biomarker of disease activity in rheumatoid arthritis during intensive treatment with csDMARDs and infliximab. Evidence from the randomised controlled NEO-RACo trial

Tuija Vaananen, Katriina Vuolteenaho, Hannu Kautiainen, Riina Nieminen, Timo Mottonen, Pekka Hannonen, Markku Korpela, Markku J. Kauppi, Kari Laiho, Oili Kaipiainen-Seppanen, Riitta Luosujarvi, Tea Uusitalo, Toini Uutela, Marjatta Leirisalo-Repo, Eeva Moilanen, NEO-RACo Study Grp

Research output: Contribution to journalArticleScientificpeer-review

Original languageEnglish
Article number0183294
JournalPLoS One
Volume12
Issue number8
Number of pages15
ISSN1932-6203
DOIs
Publication statusPublished - 25 Aug 2017
MoE publication typeA1 Journal article-refereed

Fields of Science

  • HUMAN CARTILAGE GLYCOPROTEIN-39
  • SERUM YKL-40
  • RADIOGRAPHIC PROGRESSION
  • COMBINATION THERAPY
  • PERIPHERAL-BLOOD
  • ACTIVITY SCORES
  • FOLLOW-UP
  • MHC CLASS
  • JOINT
  • INFLAMMATION
  • 3121 Internal medicine
  • 3111 Biomedicine

Cite this

Vaananen, Tuija ; Vuolteenaho, Katriina ; Kautiainen, Hannu ; Nieminen, Riina ; Mottonen, Timo ; Hannonen, Pekka ; Korpela, Markku ; Kauppi, Markku J. ; Laiho, Kari ; Kaipiainen-Seppanen, Oili ; Luosujarvi, Riitta ; Uusitalo, Tea ; Uutela, Toini ; Leirisalo-Repo, Marjatta ; Moilanen, Eeva ; NEO-RACo Study Grp. / Glycoprotein YKL-40 : A potential biomarker of disease activity in rheumatoid arthritis during intensive treatment with csDMARDs and infliximab. Evidence from the randomised controlled NEO-RACo trial. In: PLoS One. 2017 ; Vol. 12, No. 8.
@article{5a11fb21fc254b2faa9a62eeae89cd96,
title = "Glycoprotein YKL-40: A potential biomarker of disease activity in rheumatoid arthritis during intensive treatment with csDMARDs and infliximab. Evidence from the randomised controlled NEO-RACo trial",
keywords = "HUMAN CARTILAGE GLYCOPROTEIN-39, SERUM YKL-40, RADIOGRAPHIC PROGRESSION, COMBINATION THERAPY, PERIPHERAL-BLOOD, ACTIVITY SCORES, FOLLOW-UP, MHC CLASS, JOINT, INFLAMMATION, 3121 Internal medicine, 3111 Biomedicine",
author = "Tuija Vaananen and Katriina Vuolteenaho and Hannu Kautiainen and Riina Nieminen and Timo Mottonen and Pekka Hannonen and Markku Korpela and Kauppi, {Markku J.} and Kari Laiho and Oili Kaipiainen-Seppanen and Riitta Luosujarvi and Tea Uusitalo and Toini Uutela and Marjatta Leirisalo-Repo and Eeva Moilanen and {NEO-RACo Study Grp}",
year = "2017",
month = "8",
day = "25",
doi = "10.1371/journal.pone.0183294",
language = "English",
volume = "12",
journal = "PLoS One",
issn = "1932-6203",
publisher = "PUBLIC LIBRARY OF SCIENCE",
number = "8",

}

Vaananen, T, Vuolteenaho, K, Kautiainen, H, Nieminen, R, Mottonen, T, Hannonen, P, Korpela, M, Kauppi, MJ, Laiho, K, Kaipiainen-Seppanen, O, Luosujarvi, R, Uusitalo, T, Uutela, T, Leirisalo-Repo, M, Moilanen, E & NEO-RACo Study Grp 2017, 'Glycoprotein YKL-40: A potential biomarker of disease activity in rheumatoid arthritis during intensive treatment with csDMARDs and infliximab. Evidence from the randomised controlled NEO-RACo trial', PLoS One, vol. 12, no. 8, 0183294. https://doi.org/10.1371/journal.pone.0183294

Glycoprotein YKL-40 : A potential biomarker of disease activity in rheumatoid arthritis during intensive treatment with csDMARDs and infliximab. Evidence from the randomised controlled NEO-RACo trial. / Vaananen, Tuija; Vuolteenaho, Katriina; Kautiainen, Hannu; Nieminen, Riina; Mottonen, Timo; Hannonen, Pekka; Korpela, Markku; Kauppi, Markku J.; Laiho, Kari; Kaipiainen-Seppanen, Oili; Luosujarvi, Riitta; Uusitalo, Tea; Uutela, Toini; Leirisalo-Repo, Marjatta; Moilanen, Eeva; NEO-RACo Study Grp.

In: PLoS One, Vol. 12, No. 8, 0183294, 25.08.2017.

Research output: Contribution to journalArticleScientificpeer-review

TY - JOUR

T1 - Glycoprotein YKL-40

T2 - A potential biomarker of disease activity in rheumatoid arthritis during intensive treatment with csDMARDs and infliximab. Evidence from the randomised controlled NEO-RACo trial

AU - Vaananen, Tuija

AU - Vuolteenaho, Katriina

AU - Kautiainen, Hannu

AU - Nieminen, Riina

AU - Mottonen, Timo

AU - Hannonen, Pekka

AU - Korpela, Markku

AU - Kauppi, Markku J.

AU - Laiho, Kari

AU - Kaipiainen-Seppanen, Oili

AU - Luosujarvi, Riitta

AU - Uusitalo, Tea

AU - Uutela, Toini

AU - Leirisalo-Repo, Marjatta

AU - Moilanen, Eeva

AU - NEO-RACo Study Grp

PY - 2017/8/25

Y1 - 2017/8/25

KW - HUMAN CARTILAGE GLYCOPROTEIN-39

KW - SERUM YKL-40

KW - RADIOGRAPHIC PROGRESSION

KW - COMBINATION THERAPY

KW - PERIPHERAL-BLOOD

KW - ACTIVITY SCORES

KW - FOLLOW-UP

KW - MHC CLASS

KW - JOINT

KW - INFLAMMATION

KW - 3121 Internal medicine

KW - 3111 Biomedicine

U2 - 10.1371/journal.pone.0183294

DO - 10.1371/journal.pone.0183294

M3 - Article

VL - 12

JO - PLoS One

JF - PLoS One

SN - 1932-6203

IS - 8

M1 - 0183294

ER -